Medicine guide
Juvela Vitamin E Medicine in Japan: Uses, Limits and Safety
This guide to Juvela in Japan covers the vitamin E medicine, differences from Juvela N and cosmetic-use limits. It separates medicine-specific information from the product and prescription checks needed for an individual consultation.
This page explains Juvela’s uses, directions, limitations and safety. For prices and individual prescriptions, see SWIFT’s relevant care information.
Juvela 50 mg tablets are a vitamin E product. They are used for conditions including deficiency and peripheral circulatory disorders, but the Japanese prescribing information does not include removing dark spots as an indication. Check ingredients to distinguish them from Juvela N and supplements.
Medical reviewer: Masashi Morita, MD
Juvela 50 mg tablets are a vitamin E product. They are used for conditions including deficiency and peripheral circulatory disorders, but the Japanese prescribing information does not include removing dark spots as an indication. Check ingredients to distinguish them from Juvela N and supplements.
- Ingredient/class
- Tocopherol acetate
- Eligible patients/indications
- Approved indications are prevention and treatment of vitamin E deficiency, peripheral circulatory disorders and prevention of increased lipid peroxides. Do not present cosmetic use as approved dark-spot treatment in the prescribing information.
- Assessing effects
- For indications other than deficiency, the prescribing information states that use should not continue indefinitely beyond 1 month without benefit. Do not uniformly advise several months until skin lightening occurs; reassess the need during consultation.
- Clinic care
- Service information supported by public sources is identified in the article. Final prescribing decisions are made during consultation.
What the medicine is
As vitamin E, the ingredient participates in processes such as lipid oxidation. Antioxidant activity alone does not clinically guarantee prevention of aging or whole-body skin lightening.
Eligible patients and approved indications
Approved indications are prevention and treatment of vitamin E deficiency, peripheral circulatory disorders and prevention of increased lipid peroxides. Do not present cosmetic use as approved dark-spot treatment in the prescribing information.
Source: Medicine-specific primary documentation. The product used by the clinic is not assumed to be identical to the formulation in this documentation.
Using Juvela Tablets 50 mg for cosmetic goals such as dark spots or skin lightening is off-label in Japan. Distinguish this from approved treatment of deficiency or peripheral circulatory disorders, and discuss limits of expected benefits, adverse effects and alternatives with a doctor. SWIFT’s cosmetic-care information concerns self-pay care.
Japan’s Relief System for Sufferers from Adverse Drug Reactions covers qualifying serious health harm that occurs despite appropriate use. Off-label use and other circumstances may fall outside coverage. Eligibility is assessed individually in light of the purpose and manner of use and medical and pharmaceutical knowledge; discuss this with the doctor and contact PMDA if needed.
Treatment limitations and when diagnosis is needed
Effects on pigmentation or melasma cannot be uniformly guaranteed. Coldness and numbness can have other causes; investigate these rather than continuing observation with vitamin E alone.
Formulations and basic directions
Approved adult directions are 50–100 mg per dose, 2–3 times daily, adjusted for symptoms and other factors. Juvela N is a different vitamin E derivative; do not transfer the tablet count. Check total intake including supplements.
Source: Medicine-specific primary documentation. The product used by the clinic is not assumed to be identical to the formulation in this documentation.
Timing of response and decisions about continuation
For indications other than deficiency, the prescribing information states that use should not continue indefinitely beyond 1 month without benefit. Do not uniformly advise several months until skin lightening occurs; reassess the need during consultation.
Side effects and symptoms to watch for
Constipation, stomach discomfort, diarrhea and rash may occur. Seek advice for persistent troublesome symptoms.
Source: Medicine-specific primary documentation. The product used by the clinic is not assumed to be identical to the formulation in this documentation.
When to stop and seek medical attention
If rash or gastrointestinal symptoms occur, explain how you have been taking it and seek advice. Obtain medical attention promptly for sudden abnormalities such as breathing difficulty or severe systemic symptoms.
Restrictions and interactions
Disclose medicines and supplements, including anticoagulants and other vitamin E products. Few listed serious interactions do not guarantee that there are no interaction problems.
Source: Medicine-specific primary documentation. The product used by the clinic is not assumed to be identical to the formulation in this documentation.
Pregnancy, breastfeeding and patient precautions
During pregnancy or breastfeeding, discuss the need for supplementation with a doctor. For breastfeeding, the prescribing information advises considering the benefits of treatment and breast milk.
Additional care
Even for cosmetic use, sun protection and diagnosis of lesions form the foundation. Antioxidant explanations do not mean sunscreen or other treatment is unnecessary.
Storage and quality checks
Store at room temperature in the original packaging and remove tablets from the blister sheet before taking them. Do not swallow the packaging.
Differences from other medicines and treatments
Cinal combines vitamin C and calcium pantothenate and differs from Juvela in ingredients and approved indications. Juvela N contains tocopherol nicotinate and must be distinguished from Juvela 50 mg tablets.
Discussing consultation and prescribing with SWIFT
SWIFT’s official oral cosmetic medicine page lists Juvela, 90 tablets for 1 month, at JPY 1,400. Confirm the actual formulation, administration frequency and total for online care during consultation. Confirm the tax treatment and complete payable total, including consultation and shipping fees, during consultation.
Frequently asked questions
Is it the same as Juvela N?
The ingredients differ. Similar names do not make doses interchangeable.
For Juvela, is it approved for skin lightening?
The Japanese prescribing information does not list skin lightening or dark-spot removal as indications. The intended use requires explanation.
For Juvela, can I take it with supplements?
Tell the doctor the supplement names and amounts so duplicated ingredient quantities can be checked.
Medical supervision
Dr Masashi Morita (Board-certified specialist and supervising physician, Japanese Urological Association / Board-certified specialist, Japan Endocrine Society / Doctor of Medical Science).